Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Rudolf Bernard"'
Publikováno v:
Gesundheits- und Sozialpolitik. 72:48-51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::846d9076c5e2d9bd16b0933b83ed391f
https://doi.org/10.5771/1611-5821-2018-3-48
https://doi.org/10.5771/1611-5821-2018-3-48
Autor:
Christiane Querbach, Dirk H. Busch, Susanne Feihl, Jakob Thurner, Rudolf Bernard, Christian Suren, Heinrich M. L. Mühlhofer, Patrick C. Rämer, Rüdiger von Eisenhart-Rothe, Florian Pohlig
Background/aim Prosthetic joint infections (PJI) are difficult to diagnose and treat. For a correct diagnosis, an array of information has to be processed and weighted. Successful treatment depends on the diagnosis, timing, and surgical strategy pair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::731a0086d98a4d8a478f0b36abf60f4b
https://europepmc.org/articles/PMC6754993/
https://europepmc.org/articles/PMC6754993/
Autor:
Ter Horst, Wouter Lambertus Anthonie1,2,3 (AUTHOR) wouter.terhorst@hkv.nl, Jongejan, Rudolf Bernard2,3,4 (AUTHOR) Ruben.Jongejan@JongejanRMC.com
Publikováno v:
International Journal of River Basin Management. Sep2015, Vol. 13 Issue 3, p305-313. 9p.
Autor:
Christian Peschel, B. Paessens, Rudolf Bernard, C. von Schilling, Angela Ihbe-Heffinger, Karin Berger, Margarita Shlaen
Publikováno v:
Supportive Care in Cancer. 21:1665-1675
To evaluate frequency and severity of adverse drug reactions (ADRs) and its economic consequences after standard dose (immuno-)chemotherapy (CT) of non-small-cell lung cancer (NSCLC).Subanalysis of a prospective, multicentre, longitudinal, observatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79731ec9ae02fc8e11247b1a6b2cd22c
https://doi.org/10.1007/s00520-012-1711-5
https://doi.org/10.1007/s00520-012-1711-5
Autor:
Miriam, Gyalrong-Steur, Anita, Kellermann, Rudolf, Bernard, Georg, Berndt, Meike, Bindemann, Elfriede, Nusser-Rothermundt, Steffen, Amann, Myga, Brakebusch, Jörg, Brüggmann, Eva, Tydecks, Markus, Müller, Frank, Dörje, Eberhard, Kochs, Rainer, Riedel
Publikováno v:
Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen. 121
In view of the rising cost pressure and an increasing number of drug shortages, switches between generic drug preparations have become a daily routine in hospitals. To ensure consistently high treatment quality and best possible patient safety, the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::72242db6bc3e674d6c7265488ba9df67
https://pubmed.ncbi.nlm.nih.gov/28545614
https://pubmed.ncbi.nlm.nih.gov/28545614
Autor:
Marion Kiechle, Rudolf Bernard, Stefanie C Mayer, Nadia Harbeck, B. Paessens, Volker R. Jacobs, Angela Ihbe-Heffinger
Publikováno v:
Onkologie. 34:614-618
Background: In flat-rate reimbursement systems, the hospital’s own costs should not exceed its revenues. In a cohort of primary breast cancer (pBC) patients, costs and reimbursement for febrile neutropenia (FN) were compared to verify cost coverage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d89761d718128c67a81747b18a62f8f8
https://doi.org/10.1159/000334063
https://doi.org/10.1159/000334063
Autor:
Florian Lordick, Rudolf Bernard, R. Deuson, J. Thödtmann, Christian Peschel, Birgit Ehlken, H.-G. Eichler, Karin Berger, Angela Ihbe-Heffinger
Publikováno v:
Annals of Oncology. 15:526-536
Background: Delayed chemotherapy-induced nausea and vomiting (CINV) remains a major adverse effect of cancer chemotherapy. We assessed, under current practice patterns, the occurrence and impact on healthcare resource utilization of CINV in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::436c923674c1c1380129309ae6988a44
https://doi.org/10.1093/annonc/mdh110
https://doi.org/10.1093/annonc/mdh110
Autor:
Christian Peschel, Wolfgang Schramm, Christoph von Schilling, Rudolf Bernard, B. Paessens, Karin Berger, Rita Shlaen, Angela Ihbe-Heffinger
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 20(5)
The purpose of this study was to describe blood component (BC) use and respective cost after standard dose chemotherapy (CT) in routine hospital care.Analysis of data from a prospective, multicenter, longitudinal, observational study on lymphoprolife
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5131bdd11b3ab6ac20793c3d675f3d96
https://pubmed.ncbi.nlm.nih.gov/21562801
https://pubmed.ncbi.nlm.nih.gov/21562801
Autor:
B. Paessens, Volker R. Jacobs, Margarita Shlaen, Marion Kiechle, Angela Ihbe-Heffinger, Karin Berger, Christian Peschel, Christoph von Schilling, Nina Gottschalk, Rudolf Bernard
Background: Febrile neutropenia/leukopenia (FN/FL) is the most frequent dose-limiting toxicity of myelosuppressive chemotherapy, but German data on economic consequences are limited. Patients and Methods: A prospective, multicentre, longitudinal, obs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3447966b73affda25f6dd3337fb02eb2
https://mediatum.ub.tum.de/doc/1218825/document.pdf
https://mediatum.ub.tum.de/doc/1218825/document.pdf
Autor:
G. Anker, Stefan Paepke, B. Paessens, Volker R. Jacobs, U Schwarz-Boeger, S. C. Mayer, Angela Ihbe-Heffinger, Marion Kiechle, Rudolf Bernard, Nadia Harbeck
Publikováno v:
Journal of Clinical Oncology. 27:e11570-e11570
e11570 Background: Febrile neutropenia (FN) is an undesired effect of myelosuppressive chemotherapy (CTX). To date limited data on costs of FN management is available. We compared costs and reimbursement of FN in a study of BC patients during adjuvan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e5265229a18ab855e2469948353af7c
https://doi.org/10.1200/jco.2009.27.15_suppl.e11570
https://doi.org/10.1200/jco.2009.27.15_suppl.e11570